Parkwood LLC Acadia Pharmaceuticals Inc Transaction History

Parkwood LLC

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$14.62 - $18.42 $65,482 - $82,503	4,479 Added 9.68%	50,749 $825,000
Q1 2024 May 15, 2024	BUY	$17.79 - $30.86 $423,508 - $734,653	23,806 Added 105.97%	46,270 $856,000
Q4 2023 Feb 14, 2024	BUY	$20.78 - $31.77 $43,970 - $67,225	2,116 Added 10.4%	22,464 $703,000
Q3 2023 Nov 14, 2023	BUY	$20.84 - $33.47 $37,782 - $60,681	1,813 Added 9.78%	20,348 $424,000
Q2 2023 Aug 14, 2023	BUY	$17.8 - $25.65 $24,795 - $35,730	1,393 Added 8.13%	18,535 $444,000
Q1 2023 May 15, 2023	SELL	$16.32 - $20.92 $166,039 - $212,840	-10,174 Reduced 37.25%	17,142 $323,000
Q4 2022 Feb 14, 2023	BUY	$14.2 - $18.63 $126,593 - $166,086	8,915 Added 48.45%	27,316 $435,000
Q3 2022 Nov 14, 2022	SELL	$14.11 - $18.27 $90,769 - $117,530	-6,433 Reduced 25.9%	18,401 $301,000
Q2 2022 Aug 15, 2022	BUY	$13.01 - $27.22 $100,983 - $211,281	7,762 Added 45.47%	24,834 $25,000
Q1 2022 May 13, 2022	SELL	$20.94 - $27.5 $83,257 - $109,340	-3,976 Reduced 18.89%	17,072 $413,000
Q4 2021 Feb 11, 2022	SELL	$16.79 - $27.09 $126,008 - $203,310	-7,505 Reduced 26.28%	21,048 $491,000
Q3 2021 Nov 12, 2021	BUY	$15.78 - $24.77 $81,046 - $127,218	5,136 Added 21.93%	28,553 $474,000
Q2 2021 Aug 13, 2021	SELL	$19.4 - $27.42 $58,956 - $83,329	-3,039 Reduced 11.49%	23,417 $571,000
Q1 2021 May 14, 2021	BUY	$25.02 - $54.99 $24,719 - $54,330	988 Added 3.88%	26,456 $683,000
Q4 2020 Feb 12, 2021	BUY	$41.04 - $56.79 $1.05 Million - $1.45 Million	25,468 New	25,468 $1.36 Million

280

156M

901K

314K

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.63B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

Get notified when there are updates to the investment portfolio of Parkwood LLC, based on Form 13F filings with the SEC.

Stay updated on Parkwood LLC with notifications on news.